{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["carotenoids", "diabetic complications", "flavonoids", "inflammation", "oxidative stress"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37032781", "DateRevised": {"Year": "2023", "Month": "04", "Day": "12"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "03", "Day": "24"}], "Language": ["eng"], "ELocationID": ["1020950", "10.3389/fnut.2023.1020950"], "Journal": {"ISSN": "2296-861X", "JournalIssue": {"Volume": "10", "PubDate": {"Year": "2023"}}, "Title": "Frontiers in nutrition", "ISOAbbreviation": "Front Nutr"}, "ArticleTitle": "The protective effects of flavonoids and carotenoids against diabetic complications-A review of <i>in vivo</i> evidence.", "Pagination": {"StartPage": "1020950", "MedlinePgn": "1020950"}, "Abstract": {"AbstractText": ["Diabetes mellitus is a chronic metabolic disorder caused either by inadequate insulin secretion, impaired insulin function, or both. Uncontrolled diabetes is characterized by hyperglycemia which over time leads to fatal damage to both macro-and microvascular systems, causing complications such as cardiovascular diseases, retinopathy and nephropathy. Diabetes management is conventionally delivered through modifications of diet and lifestyle and pharmacological treatment, using antidiabetic drugs, and ultimately insulin injections. However, the side effects and financial cost of medications often reduce patient compliance to treatment, negatively affecting their health outcomes. Natural phytochemicals from edible plants such as fruits and vegetables (F&V) and medicinal herbs have drawn a growing interest as potential therapeutic agents for treating diabetes and preventing the onset and progression of diabetic complications. Flavonoids, the most abundant polyphenols in the human diet, have shown antidiabetic effects in numerous <i>in vitro</i> and preclinical studies. The underlying mechanisms have been linked to their antioxidant, anti-inflammatory and immunomodulatory activities. Carotenoids, another major group of dietary phytochemicals, have also shown antidiabetic potential in recent <i>in vitro</i> and <i>in vivo</i> experimental models, possibly through a mechanism of action similar to that of flavonoids. However, scientific evidence on the efficacy of these phytochemicals in treating diabetes or preventing the onset and progression of its complications in clinical settings is scarce, which delays the translation of animal study evidence to human applications and also limits the knowledge on their modes of actions in diabetes management. This review is aimed to highlight the potential roles of flavonoids and carotenoids in preventing or ameliorating diabetes-related complications based on <i>in vivo</i> study evidence, i.e., an array of preclinical animal studies and human intervention trials. The current general consensus of the underlying mechanisms of action exerted by both groups of phytochemicals is that their anti-inflammatory action is key. However, other potential mechanisms of action are considered. In total, 50 <i>in vivo</i> studies were selected for a review after a comprehensive database search <i>via</i> PubMed and ScienceDirect from January 2002 to August 2022. The key words used for analysis are type-2 diabetes (T2DM), diabetic complications, flavonoids, carotenoids, antioxidant, anti-inflammatory, mechanisms of prevention and amelioration, animal studies and human interventions."], "CopyrightInformation": "Copyright \u00a9 2023 Jin and Arroo."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Leicester School of Allied Health Sciences, Faculty of Health & Life Sciences, De Montfort University, Leicester, United Kingdom."}], "LastName": "Jin", "ForeName": "Yannan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Leicester School of Pharmacy, Faculty of Health & Life Sciences, De Montfort University, Leicester, United Kingdom."}], "LastName": "Arroo", "ForeName": "Randolph", "Initials": "R"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Nutr", "NlmUniqueID": "101642264", "ISSNLinking": "2296-861X"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Craig ME, Hattersley A, Donaghue KC. Definition, epidemiology and classification of diabetes in children and adolescents. Pediatr Diabetes. (2009) 10:3S\u201312S. doi: 10.1111/j.1399-5448.2009.00568", "ArticleIdList": ["10.1111/j.1399-5448.2009.00568", "19754613"]}, {"Citation": "Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. . Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9(th) edition. Diabetes Res Clin Pract. (2019) 157:107843. doi: 10.1016/j.diabres.2019.107843, PMID:", "ArticleIdList": ["10.1016/j.diabres.2019.107843", "31518657"]}, {"Citation": "Williams R, Karuranga S, Malanda B, Saeedi P, Basit A, Besancon S, et al. . Global and regional estimates and projections of diabetes-related health expenditure: results from the international diabetes federation diabetes atlas, 9th edition. Diabetes Res Clin Pract. (2020) 162:108072. doi: 10.1016/j.diabres.2020.108072", "ArticleIdList": ["10.1016/j.diabres.2020.108072", "32061820"]}, {"Citation": "Irwin S. Chapter 10-primary prevention and risk reduction for cardiovascular/pulmonary disorders\u2014preferred practice pattern 6A In: Irwin S, Tecklin JS, editors. Cardiopulmonary Physical Therapy. 4th ed. Saint Louis: Mosby; (2004). 253\u201369."}, {"Citation": "Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, et al. . Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. (1999) 100:1134\u201346. doi: 10.1161/01.cir.100.10.1134", "ArticleIdList": ["10.1161/01.cir.100.10.1134", "10477542"]}, {"Citation": "Kong M, Xie K, Lv M, Li J, Yao J, Yan K, et al. . Anti-inflammatory phytochemicals for the treatment of diabetes and its complications: lessons learned and future promise. Biomed Pharmacother. (2021) 133:110975. doi: 10.1016/j.biopha.2020.110975, PMID:", "ArticleIdList": ["10.1016/j.biopha.2020.110975", "33212375"]}, {"Citation": "Boni-Schnetzler M, Thorne J, Parnaud G, Marselli L, Ehses JA, Kerr-Conte J, et al. . Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta-cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation. J Clin Endocrinol Metab. (2008) 93:4065\u201374. doi: 10.1210/jc.2008-0396, PMID:", "ArticleIdList": ["10.1210/jc.2008-0396", "PMC2579638", "18664535"]}, {"Citation": "Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes. (2008) 57:1446\u201354. doi: 10.2337/db08-0057, PMID:", "ArticleIdList": ["10.2337/db08-0057", "18511445"]}, {"Citation": "Aiello LP, Bursell SE, Clermont A, Duh E, Ishii H, Takagi C, et al. . Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes. (1997) 46:1473\u201380. doi: 10.2337/diab.46.9.1473, PMID:", "ArticleIdList": ["10.2337/diab.46.9.1473", "9287049"]}, {"Citation": "Pollack RM, Donath MY, LeRoith D, Leibowitz G. Anti-inflammatory agents in the treatment of diabetes and its vascular complications. Diabetes Care. (2016) 39:S244\u201352. doi: 10.2337/dcS15-3015", "ArticleIdList": ["10.2337/dcS15-3015", "27440839"]}, {"Citation": "Caro-Ordieres T, Marin-Royo G, Opazo-Rios L, Jimenez-Castilla L, Moreno JA, Gomez-Guerrero C, et al. . The coming age of flavonoids in the treatment of diabetic complications. J Clin Med. (2020) 9:10. doi: 10.3390/jcm9020346", "ArticleIdList": ["10.3390/jcm9020346", "PMC7074336", "32012726"]}, {"Citation": "Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes. (2011) 29:116\u201322. doi: 10.2337/diaclin.29.3.116", "ArticleIdList": ["10.2337/diaclin.29.3.116"]}, {"Citation": "Faselis C, Katsimardou A, Imprialos K, Deligkaris P, Kallistratos M, Dimitriadis K. Microvascular complications of type 2 diabetes mellitus. Curr Vasc Pharmacol. (2020) 18:117\u201324. doi: 10.2174/1570161117666190502103733", "ArticleIdList": ["10.2174/1570161117666190502103733", "31057114"]}, {"Citation": "Selby NM, Taal MW. An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines. Diabetes Obes Metab. (2020) 22:3\u201315. doi: 10.1111/dom.14007, PMID:", "ArticleIdList": ["10.1111/dom.14007", "32267079"]}, {"Citation": "Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. . Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. (2012) 35:556\u201364. doi: 10.2337/dc11-1909, PMID:", "ArticleIdList": ["10.2337/dc11-1909", "PMC3322721", "22301125"]}, {"Citation": "Ting DS, Cheung GC, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol. (2016) 44:260\u201377. doi: 10.1111/ceo.12696, PMID:", "ArticleIdList": ["10.1111/ceo.12696", "26716602"]}, {"Citation": "Chistiakov DA. Diabetic retinopathy: pathogenic mechanisms and current treatments. Diabetes Metab Syndr. (2011) 5:165\u201372. doi: 10.1016/j.dsx.2012.02.025, PMID:", "ArticleIdList": ["10.1016/j.dsx.2012.02.025", "22813573"]}, {"Citation": "Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, et al. . Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. (2017) 40:136\u201354. doi: 10.2337/dc16-2042, PMID:", "ArticleIdList": ["10.2337/dc16-2042", "PMC6977405", "27999003"]}, {"Citation": "Kuhad A, Sharma S, Chopra K. Lycopene attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain. Eur J Pain. (2008) 12:624\u201332. doi: 10.1016/j.ejpain.2007.10.008, PMID:", "ArticleIdList": ["10.1016/j.ejpain.2007.10.008", "18055235"]}, {"Citation": "Farmer KL, Li C, Dobrowsky RT. Diabetic peripheral neuropathy: should a chaperone accompany our therapeutic approach? Pharmacol Rev. (2012) 64:880\u2013900. doi: 10.1124/pr.111.005314, PMID:", "ArticleIdList": ["10.1124/pr.111.005314", "PMC3462992", "22885705"]}, {"Citation": "Chaudhury A, Duvoor C, Reddy Dendi VS, Kraleti S, Chada A, Ravilla R, et al. . Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management. Front Endocrinol (Lausanne). (2017) 8:6. doi: 10.3389/fendo.2017.00006, PMID:", "ArticleIdList": ["10.3389/fendo.2017.00006", "PMC5256065", "28167928"]}, {"Citation": "Carter P, Gray LJ, Troughton J, Khunti K, Davies MJ. Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis. BMJ. (2010) 341:c4229. doi: 10.1136/bmj.c4229, PMID:", "ArticleIdList": ["10.1136/bmj.c4229", "PMC2924474", "20724400"]}, {"Citation": "Cooper AJ, Forouhi NG, Ye Z, Buijsse B, Arriola L, Balkau B, et al. . Fruit and vegetable intake and type 2 diabetes: EPIC-InterAct prospective study and meta-analysis. Eur J Clin Nutr. (2012) 66:1082\u201392. doi: 10.1038/ejcn.2012.85, PMID:", "ArticleIdList": ["10.1038/ejcn.2012.85", "PMC3652306", "22854878"]}, {"Citation": "Shin SA, Joo BJ, Lee JS, Ryu G, Han M, Kim WY, et al. . Phytochemicals as anti-inflammatory agents in animal models of prevalent inflammatory diseases. Molecules. (2020) 25:5932. doi: 10.3390/molecules25245932, PMID:", "ArticleIdList": ["10.3390/molecules25245932", "PMC7765227", "33333788"]}, {"Citation": "Bucolo C, Leggio GM, Drago F, Salomone S. Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic rats. Biochem Pharmacol. (2012) 84:88\u201392. doi: 10.1016/j.bcp.2012.03.019, PMID:", "ArticleIdList": ["10.1016/j.bcp.2012.03.019", "22484312"]}, {"Citation": "Ozawa Y, Sasaki M, Takahashi N, Kamoshita M, Miyake S, Tsubota K. Neuroprotective effects of lutein in the retina. Curr Pharm Des. (2012) 18:51\u20136. doi: 10.2174/138161212798919101, PMID:", "ArticleIdList": ["10.2174/138161212798919101", "PMC3319923", "22211688"]}, {"Citation": "Calabr\u00f3 V, Litterio MC, Fraga CG, Galleano M, Piotrkowski B. Effects of quercetin on heart nitric oxide metabolism in l-NAME treated rats. Arch Biochem Biophys. (2018) 647:47\u201353. doi: 10.1016/j.abb.2018.03.041, PMID:", "ArticleIdList": ["10.1016/j.abb.2018.03.041", "29621523"]}, {"Citation": "Han S, Luo Y, Hu Z, Qin D, Luo F. Targeting gut microbiota in type 2 diabetes mellitus: potential roles of dietary flavonoids. Food Biosci. (2022) 45:101500. doi: 10.1016/j.fbio.2021.101500", "ArticleIdList": ["10.1016/j.fbio.2021.101500"]}, {"Citation": "Xu H, Luo J, Huang J, Wen Q. Flavonoids intake and risk of type 2 diabetes mellitus: a meta-analysis of prospective cohort studies. Medicine (Baltimore). (2018) 97:e0686. doi: 10.1097/MD.0000000000010686, PMID:", "ArticleIdList": ["10.1097/MD.0000000000010686", "PMC5959406", "29742713"]}, {"Citation": "Sluijs I, Cadier E, Beulens JW, Van Der ADL SAM, van der Schouw YT. Dietary intake of carotenoids and risk of type 2 diabetes. Nutr Metab Cardiovasc Dis. (2015) 25:376\u201381. doi: 10.1016/j.numecd, PMID:", "ArticleIdList": ["10.1016/j.numecd", "25716098"]}, {"Citation": "Simil\u00e4 ME, Kontto JP, Virtamo J, H\u00e4t\u00f6nen KA, Valsta LM, Sundvall J, et al. . Insulin-like growth factor I, binding proteins \u22121 and \u22123, risk of type 2 diabetes and macronutrient intakes in men. Br J Nutr. (2019) 121:938\u201344. doi: 10.1017/S0007114519000321, PMID:", "ArticleIdList": ["10.1017/S0007114519000321", "30898176"]}, {"Citation": "Sluijs I, Beulens JW, Grobbee DE, van der Schouw YT. Dietary carotenoid intake is associated with lower prevalence of metabolic syndrome in middle-aged and elderly men. J Nutr. (2009) 139:987\u201392. doi: 10.3945/jn.108.101451, PMID:", "ArticleIdList": ["10.3945/jn.108.101451", "19321578"]}, {"Citation": "Cao H, Ou J, Chen L, Zhang Y, Szkudelski T, Delmas D, et al. . Dietary polyphenols and type 2 diabetes: human study and clinical trial. Crit Rev Food Sci Nutr. (2019) 59:3371\u20139. doi: 10.1080/10408398.2018.1492900", "ArticleIdList": ["10.1080/10408398.2018.1492900", "29993262"]}, {"Citation": "Jin Y, Arroo RRJ. Application of dietary supplements in the prevention of type 2 diabetes-related cardiovascular complications. Phytochem Rev. (2021) 20:181\u2013209. doi: 10.1007/s11101-020-09710-8", "ArticleIdList": ["10.1007/s11101-020-09710-8"]}, {"Citation": "Hollman PC, Katan MB. Dietary flavonoids: intake, health effects and bioavailability. Food Chem Toxicol. (1999) 37:937\u201342. doi: 10.1016/s0278-6915(99)00079-4", "ArticleIdList": ["10.1016/s0278-6915(99)00079-4", "10541448"]}, {"Citation": "Katiyar SK, Meleth S, Sharma SD. Silymarin, a flavonoid from milk thistle (Silybum marianum L.), inhibits UV-induced oxidative stress through targeting infiltrating CD11b+ cells in mouse skin. Photochem Photobiol. (2008) 84:266\u201371. doi: 10.1111/j.1751-1097.2007.00241.x, PMID:", "ArticleIdList": ["10.1111/j.1751-1097.2007.00241.x", "PMC2394725", "18221354"]}, {"Citation": "Waheed Janabi AH, Kamboh AA, Saeed M, Xiaoyu L, BiBi J, Majeed F, et al. . Flavonoid-rich foods (FRF): a promising nutraceutical approach against lifespan-shortening diseases. Iran J Basic Med Sci. (2020) 23:140\u201353. doi: 10.22038/IJBMS.2019.35125.8353, PMID:", "ArticleIdList": ["10.22038/IJBMS.2019.35125.8353", "PMC7211351", "32405356"]}, {"Citation": "Lotfollahi Z, Mello APQ, Costa ES, et al. . Green-banana biomass consumption by diabetic patients improves plasma low-density lipoprotein particle functionality. Sci Rep. (2020) 10:12269. doi: 10.1038/s41598-020-69288-1, PMID:", "ArticleIdList": ["10.1038/s41598-020-69288-1", "PMC7378544", "32704082"]}, {"Citation": "Dabeek WM, Marra MV. Dietary Quercetin and Kaempferol: bioavailability and potential cardiovascular-related bioactivity in humans. Nutrients. (2019) 11:2288. doi: 10.3390/nu11102288, PMID:", "ArticleIdList": ["10.3390/nu11102288", "PMC6835347", "31557798"]}, {"Citation": "He P, Yan S, Wen X, Zhang S, Liu Z, Liu X, et al. . Eriodictyol alleviates lipopolysaccharide-triggered oxidative stress and synaptic dysfunctions in BV-2 microglial cells and mouse brain. J Cell Biochem. (2019) 120:14756\u201370. doi: 10.1002/jcb.28736, PMID:", "ArticleIdList": ["10.1002/jcb.28736", "31016762"]}, {"Citation": "Neuhouser ML. Dietary flavonoids and cancer risk: evidence from human population studies. Nutr Cancer. (2004) 50:1\u20137. doi: 10.1207/s15327914nc5001_1, PMID:", "ArticleIdList": ["10.1207/s15327914nc5001_1", "15572291"]}, {"Citation": "Stompor-Gor\u0105cy M, Bajek-Bil A, Machaczka M. Chrysin: perspectives on contemporary status and future possibilities as pro-health agent. Nutrients. (2021) 13:2038. doi: 10.3390/nu13062038, PMID:", "ArticleIdList": ["10.3390/nu13062038", "PMC8232110", "34198618"]}, {"Citation": "Benavente-Garc\u00eda O, Castillo J. Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity. J Agric Food Chem. (2008) 56:6185\u2013205. doi: 10.1021/jf8006568, PMID:", "ArticleIdList": ["10.1021/jf8006568", "18593176"]}, {"Citation": "Spagnuolo C, Russo GL, Orhan IE, Habtemariam S, Daglia M, Sureda A, et al. . Genistein and cancer: current status, challenges, and future directions. Adv Nutr. (2015) 6:408\u201319. doi: 10.3945/an.114.008052, PMID:", "ArticleIdList": ["10.3945/an.114.008052", "PMC4496735", "26178025"]}, {"Citation": "James KD, Forester SC, Lambert JD. Dietary pretreatment with green tea polyphenol, (\u2212)-epigallocatechin-3-gallate reduces the bioavailability and hepatotoxicity of subsequent oral bolus doses of (\u2212)-epigallocatechin-3-gallate. Food Chem Toxicol. (2015) 76:103\u20138. doi: 10.1016/j.fct.2014.12.009, PMID:", "ArticleIdList": ["10.1016/j.fct.2014.12.009", "PMC4383035", "25528115"]}, {"Citation": "Erlund I. Review of the flavonoids quercetin, hesperetin, and naringenin. Dietary sources, bioactivities, bioavailability, and epidemiology. Nutr Res. (2004) 24:851\u201374. doi: 10.1016/j.nutres.2004.07.005", "ArticleIdList": ["10.1016/j.nutres.2004.07.005"]}, {"Citation": "Khoo HE, Azlan A, Tang ST, Lim SM. Anthocyanidins and anthocyanins: colored pigments as food, pharmaceutical ingredients, and the potential health benefits. Food Nutr Res. (2017) 61:1361779. doi: 10.1080/16546628.2017.1361779, PMID:", "ArticleIdList": ["10.1080/16546628.2017.1361779", "PMC5613902", "28970777"]}, {"Citation": "Choe U, Whent M, Luo Y, Yu L. Total phenolic content, free radical scavenging capacity, and anti-cancer activity of silymarin. J Food Bioact. (2020) 10:53\u201363. doi: 10.31665/JFB.2020.10226", "ArticleIdList": ["10.31665/JFB.2020.10226"]}, {"Citation": "El-SM A-A, Akhtar H, Zaheer K, Ali R. Dietary sources of lutein and zeaxanthin carotenoids and their role in eye health. Nutrients. (2013) 5:1169\u201385. doi: 10.3390/nu5041169, PMID:", "ArticleIdList": ["10.3390/nu5041169", "PMC3705341", "23571649"]}, {"Citation": "Sommerburg O, Keunen JE, Bird AC, van Kuijk FJ. Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes. Br J Ophthalmol. (1998) 82:907\u201310. doi: 10.1136/bjo.82.8.907, PMID:", "ArticleIdList": ["10.1136/bjo.82.8.907", "PMC1722697", "9828775"]}, {"Citation": "Ambati RR, Phang SM, Ravi S, Aswathanarayana RG. Astaxanthin: sources, extraction, stability, biological activities and its commercial applications--a review. Mar Drugs. (2014) 12:128\u201352. doi: 10.3390/md12010128, PMID:", "ArticleIdList": ["10.3390/md12010128", "PMC3917265", "24402174"]}, {"Citation": "Khan UM, Sevindik M, Zarrabi A, Nami M, Ozdemir B, Kaplan DN, et al. . Lycopene: food sources, biological activities, and human health benefits. Oxidative Med Cell Longev. (2021) 2021:2713511\u201320. doi: 10.1155/2021/2713511, PMID:", "ArticleIdList": ["10.1155/2021/2713511", "PMC8626194", "34840666"]}, {"Citation": "Akram S, Mushtaq M, Waheed A. Chapter 1-\u03b2-carotene: beyond provitamin a In: Mushtaq M, Anwar F, editors. A Centum of Valuable Plant Bioactives: Academic Press; (2021). 1\u201331."}, {"Citation": "Fathalipour M, Fathalipour H, Safa O, Nowrouzi-Sohrabi P, Mirkhani H, Hassanipour S. The therapeutic role of carotenoids in diabetic retinopathy: a systematic review. Diabetes Metab Syndr Obes. (2020) 13:2347\u201358. doi: 10.2147/DMSO.S255783, PMID:", "ArticleIdList": ["10.2147/DMSO.S255783", "PMC7342496", "32753919"]}, {"Citation": "Milani A, Basirnejad M, Shahbazi S, Bolhassani A. Carotenoids: biochemistry, pharmacology and treatment. Br J Pharmacol. (2017) 174:1290\u2013324. doi: 10.1111/bph.13625, PMID:", "ArticleIdList": ["10.1111/bph.13625", "PMC5429337", "27638711"]}, {"Citation": "Murillo AG, Fernandez ML. Potential of dietary non-Provitamin a carotenoids in the prevention and treatment of diabetic microvascular complications. Adv Nutr. (2016) 7:14\u201324. doi: 10.3945/an.115.009803, PMID:", "ArticleIdList": ["10.3945/an.115.009803", "PMC4717886", "26773012"]}, {"Citation": "Lem DW, Gierhart DL, Davey PG. A systematic review of carotenoids in the management of diabetic retinopathy. Nutrients. (2021) 13:2441. doi: 10.3390/nu13072441, PMID:", "ArticleIdList": ["10.3390/nu13072441", "PMC8308772", "34371951"]}, {"Citation": "Tan BL, Norhaizan ME. Carotenoids: how effective are they to prevent age-related diseases? Molecules. (2019) 24:1801. doi: 10.3390/molecules24091801, PMID:", "ArticleIdList": ["10.3390/molecules24091801", "PMC6539799", "31075966"]}, {"Citation": "Mahmoud MF, Hassan NA, El Bassossy HM, Fahmy A. Quercetin protects against diabetes-induced exaggerated vasoconstriction in rats: effect on low grade inflammation. PLoS One. (2013) 8:e63784. doi: 10.1371/journal.pone.0063784, PMID:", "ArticleIdList": ["10.1371/journal.pone.0063784", "PMC3661670", "23717483"]}, {"Citation": "Luo C, Yang H, Tang C, Yao G, Kong L, He H, et al. . Kaempferol alleviates insulin resistance via hepatic IKK/NF-kappaB signal in type 2 diabetic rats. Int Immunopharmacol. (2015) 28:744\u201350. doi: 10.1016/j.intimp.2015.07.018, PMID:", "ArticleIdList": ["10.1016/j.intimp.2015.07.018", "26263168"]}, {"Citation": "Gupta SK, Dongare S, Mathur R, Mohanty IR, Srivastava S, Mathur S, et al. . Genistein ameliorates cardiac inflammation and oxidative stress in streptozotocin-induced diabetic cardiomyopathy in rats. Mol Cell Biochem. (2015) 408:63\u201372. doi: 10.1007/s11010-015-2483-2, PMID:", "ArticleIdList": ["10.1007/s11010-015-2483-2", "26092427"]}, {"Citation": "Li L, Luo W, Qian Y, Zhu W, Qian J, Li J, et al. . Luteolin protects against diabetic cardiomyopathy by inhibiting NF-kappaB-mediated inflammation and activating the Nrf2-mediated antioxidant responses. Phytomedicine. (2019) 59:152774. doi: 10.1016/j.phymed.2018.11.034, PMID:", "ArticleIdList": ["10.1016/j.phymed.2018.11.034", "31009852"]}, {"Citation": "Othman AI, El-Sawi MR, El-Missiry MA, Abukhalil MH. Epigallocatechin-3-gallate protects against diabetic cardiomyopathy through modulating the cardiometabolic risk factors, oxidative stress, inflammation, cell death and fibrosis in streptozotocin-nicotinamide-induced diabetic rats. Biomed Pharmacother. (2017) 94:362\u201373. doi: 10.1016/j.biopha.2017.07.129, PMID:", "ArticleIdList": ["10.1016/j.biopha.2017.07.129", "28772214"]}, {"Citation": "Chen YF, Shibu MA, Fan MJ, Chen MC, Viswanadha VP, Lin YL, et al. . Purple rice anthocyanin extract protects cardiac function in STZ-induced diabetes rat hearts by inhibiting cardiac hypertrophy and fibrosis. J Nutr Biochem. (2016) 31:98\u2013105. doi: 10.1016/j.jnutbio.2015.12.020, PMID:", "ArticleIdList": ["10.1016/j.jnutbio.2015.12.020", "27133428"]}, {"Citation": "Kumar B, Gupta SK, Srinivasan BP, Nag TC, Srivastava S, Saxena R, et al. . Hesperetin rescues retinal oxidative stress, neuroinflammation and apoptosis in diabetic rats. Microvasc Res. (2013) 87:65\u201374. doi: 10.1016/j.mvr.2013.01.002, PMID:", "ArticleIdList": ["10.1016/j.mvr.2013.01.002", "23376836"]}, {"Citation": "Tsai SJ, Huang CS, Mong MC, Kam WY, Huang HY, Yin MC. Anti-inflammatory and antifibrotic effects of naringenin in diabetic mice. J Agric Food Chem. (2012) 60:514\u201321. doi: 10.1021/jf203259h, PMID:", "ArticleIdList": ["10.1021/jf203259h", "22117528"]}, {"Citation": "Ahad A, Ganai AA, Mujeeb M, Siddiqui WA. Chrysin, an anti-inflammatory molecule, abrogates renal dysfunction in type 2 diabetic rats. Toxicol Appl Pharmacol. (2014) 279:1\u20137. doi: 10.1016/j.taap.2014.05.007, PMID:", "ArticleIdList": ["10.1016/j.taap.2014.05.007", "24848621"]}, {"Citation": "Homayouni F, Haidari F, Hedayati M, Zakerkish M, Ahmadi K. Blood pressure lowering and anti-inflammatory effects of hesperidin in type 2 diabetes; a randomized double-blind controlled clinical trial. Phytother Res. (2018) 32:1073\u20139. doi: 10.1002/ptr.6046, PMID:", "ArticleIdList": ["10.1002/ptr.6046", "29468764"]}, {"Citation": "Hadi S, Alipour M, Aghamohammadi V, Shahemi S, Ghafouri-Taleghani F, Pourjavidi N, et al. . Improvement in fasting blood sugar, anthropometric measurement and hs-CRP after consumption of epigallocatechin3-gallate (EGCG) in patients with type 2 diabetes mellitus. Nutr Food Sci. (2020) 50:348\u201359. doi: 10.1108/NFS-04-2019-0126", "ArticleIdList": ["10.1108/NFS-04-2019-0126"]}, {"Citation": "Stote KS, Wilson MM, Hallenbeck D, Thomas K, Rourke JM, Sweeney MI, et al. . Effect of blueberry consumption on Cardiometabolic health parameters in men with type 2 diabetes: an 8-week, double-blind, randomized, placebo-controlled trial. Curr Dev Nutr. (2020) 4:nzaa030. doi: 10.1093/cdn/nzaa030, PMID:", "ArticleIdList": ["10.1093/cdn/nzaa030", "PMC7170047", "32337475"]}, {"Citation": "Fallahzadeh MK, Dormanesh B, Sagheb MM, Roozbeh J, Vessal G, Pakfetrat M, et al. . Effect of addition of silymarin to renin-angiotensin system inhibitors on proteinuria in type 2 diabetic patients with overt nephropathy: a randomized, double-blind, placebo-controlled trial. Am J Kidney Dis. (2012) 60:896\u2013903. doi: 10.1053/j.ajkd.2012.06.005, PMID:", "ArticleIdList": ["10.1053/j.ajkd.2012.06.005", "22770926"]}, {"Citation": "Zakerkish M, Jenabi M, Zaeemzadeh N, Hemmati AA, Neisi N. The effect of Iranian Propolis on glucose metabolism, lipid profile, insulin resistance, renal function and inflammatory biomarkers in patients with type 2 diabetes mellitus: a randomized double-blind clinical trial. Sci Rep. (2019) 9:7289\u20138. doi: 10.1038/s41598-019-43838-8, PMID:", "ArticleIdList": ["10.1038/s41598-019-43838-8", "PMC6514000", "31086222"]}, {"Citation": "Forte R, Cennamo G, Bonavolonta P, Pascotto A, de Crecchio G, Cennamo G. Long-term follow-up of oral administration of flavonoids, Centella asiatica and Melilotus, for diabetic cystoid macular edema without macular thickening. J Ocul Pharmacol Ther. (2013) 29:733\u20137. doi: 10.1089/jop.2013.0010, PMID:", "ArticleIdList": ["10.1089/jop.2013.0010", "23844756"]}, {"Citation": "Takano K, Nakaima K, Nitta M, Shibata F, Nakagawa H. Inhibitory effect of ()-epigallocatechin 3-gallate, a polyphenol of green tea, on neutrophil chemotaxis in vitro and in vivo. J Agric Food Chem. (2004) 52:4571\u20136. doi: 10.1021/jf0355194, PMID:", "ArticleIdList": ["10.1021/jf0355194", "15237969"]}, {"Citation": "Mochizuki K, Tan Y, Uchiyama Y, Suzuki T, Hariya N, Goda T. Supplementation with lower doses of EGCG reduces liver injury markers of type 2 diabetic rats. FundamToxicolSci. (2019) 6:15\u201323. doi: 10.2131/fts.6.15", "ArticleIdList": ["10.2131/fts.6.15"]}, {"Citation": "Sahin K, Smith MO. Regulation of transcription factors by the epigallocatechin-3-gallate in poultry reared under heat stress. Worlds Poult Sci J. (2016) 72:299\u2013306. doi: 10.1017/S0043933916000209", "ArticleIdList": ["10.1017/S0043933916000209"]}, {"Citation": "Evert AB, Dennison M, Gardner CD, Garvey WT, Lau KHK, MacLeod J, et al. . Nutrition therapy for adults with diabetes or prediabetes: a consensus report. Diabetes Care. (2019) 42:731\u201354. doi: 10.2337/dci19-0014, PMID:", "ArticleIdList": ["10.2337/dci19-0014", "PMC7011201", "31000505"]}, {"Citation": "Diabetes prevention program (DPP) research group . The diabetes prevention program (DPP): description of lifestyle intervention. Diabetes Care. (2002) 25:2165\u201371. doi: 10.2337/diacare.25.12.2165, PMID:", "ArticleIdList": ["10.2337/diacare.25.12.2165", "PMC1282458", "12453955"]}, {"Citation": "Redan BW, Buhman KK, Novotny JA, Ferruzzi MG. Altered transport and metabolism of phenolic compounds in obesity and diabetes: implications for functional food development and assessment. Adv Nutr. (2016) 7:1090\u2013104. doi: 10.3945/an.116.013029, PMID:", "ArticleIdList": ["10.3945/an.116.013029", "PMC5105043", "28140326"]}, {"Citation": "Sforcin JM. Biological properties and Terapeutic applications of Propolis. Phytother Res. (2016) 30:894\u2013905. doi: 10.1002/ptr.5605", "ArticleIdList": ["10.1002/ptr.5605", "26988443"]}, {"Citation": "Tang L, Zhang Y, Jiang Y, Willard L, Ortiz E, Wark L, et al. . Dietary wolfberry ameliorates retinal structure abnormalities in db/db mice at the early stage of diabetes. Exp Biol Med. (2011) 236:1051\u201363. doi: 10.1258/ebm.2011.010400, PMID:", "ArticleIdList": ["10.1258/ebm.2011.010400", "PMC3166358", "21750018"]}, {"Citation": "Muriach M, Bosch-Morell F, Alexander G, Blomhoff R, Barcia J, Arnal E, et al. . Lutein effect on retina and hippocampus of diabetic mice. Free Radic Biol Med. (2006) 41:979\u201384. doi: 10.1016/j.freeradbiomed.2006.06.023, PMID:", "ArticleIdList": ["10.1016/j.freeradbiomed.2006.06.023", "16934681"]}, {"Citation": "Kowluru RA, Menon B, Gierhart DL. Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats. Invest Ophthalmol Vis Sci. (2008) 49:1645\u201351. doi: 10.1167/iovs.07-0764, PMID:", "ArticleIdList": ["10.1167/iovs.07-0764", "18385086"]}, {"Citation": "Li W, Wang G, Lu X, Jiang Y, Xu L, Zhao X. Lycopene ameliorates renal function in rats with streptozotocin-induced diabetes. Int J Clin Exp Pathol. (2014) 7:5008\u201315. PMID:", "ArticleIdList": ["PMC4152062", "25197372"]}, {"Citation": "Zheng Z, Yin Y, Lu R, Jiang Z. Lycopene ameliorated oxidative stress and inflammation in type 2 diabetic rats. J Food Sci. (2019) 84:1194\u2013200. doi: 10.1111/1750-3841.14505, PMID:", "ArticleIdList": ["10.1111/1750-3841.14505", "31012961"]}, {"Citation": "Naito Y, Uchiyama K, Aoi W, Hasegawa G, Nakamura N, Yoshida N, et al. . Prevention of diabetic nephropathy by treatment with astaxanthin in diabetic db/db mice. Biofactors. (2004) 20:49\u201359. doi: 10.1002/biof.5520200105, PMID:", "ArticleIdList": ["10.1002/biof.5520200105", "15096660"]}, {"Citation": "Dong LY, Jin J, Lu G, Kang XL. Astaxanthin attenuates the apoptosis of retinal ganglion cells in db/db mice by inhibition of oxidative stress. Mar Drugs. (2013) 11:960\u201374. doi: 10.3390/md11030960, PMID:", "ArticleIdList": ["10.3390/md11030960", "PMC3705382", "23519150"]}, {"Citation": "Yeh PT, Huang HW, Yang CM, Yang WS, Yang CH. Astaxanthin inhibits expression of retinal oxidative stress and inflammatory mediators in Streptozotocin-induced diabetic rats. PLoS One. (2016) 11:e0146438. doi: 10.1371/journal.pone.0146438, PMID:", "ArticleIdList": ["10.1371/journal.pone.0146438", "PMC4713224", "26765843"]}, {"Citation": "Aydin EP, Uyar ET. Chapter 25-Thioredoxin as an antioxidant protein as a marker in depression In: Martin CR, Hunter L, Patel VB, Preedy VR, Rajendram R, editors. The Neuroscience of Depression: Academic Press; (2021). 251\u201360."}, {"Citation": "Candas D, Li JJ. MnSOD in oxidative stress response-potential regulation via mitochondrial protein influx. Antioxid Redox Signal. (2014) 20:1599\u2013617. doi: 10.1089/ars.2013.5305, PMID:", "ArticleIdList": ["10.1089/ars.2013.5305", "PMC3942709", "23581847"]}, {"Citation": "Kops GJ, Dansen TB, Polderman PE, Saarloos I, Wirtz KW, Coffer PJ, et al. . Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature. (2002) 419:316\u201321. doi: 10.1038/nature01036, PMID:", "ArticleIdList": ["10.1038/nature01036", "12239572"]}, {"Citation": "Li XN, Song J, Zhang L, LeMaire SA, Hou X, Zhang C, et al. . Activation of the AMPK-FOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin. Diabetes. (2009) 58:2246\u201357. doi: 10.2337/db08-1512, PMID:", "ArticleIdList": ["10.2337/db08-1512", "PMC2750236", "19592618"]}, {"Citation": "G\u00f6rlach A, Klappa P, Kietzmann T. The endoplasmic reticulum: folding, calcium homeostasis, signaling, and redox control. Antioxid Redox Signal. (2006) 8:1391\u2013418. doi: 10.1089/ars.2006.8.1391, PMID:", "ArticleIdList": ["10.1089/ars.2006.8.1391", "16986999"]}, {"Citation": "Rutter GA, Leclerc I. The AMP-regulated kinase family: enigmatic targets for diabetes therapy. Mol Cell Endocrinol. (2009) 297:41\u20139. doi: 10.1016/j.mce.2008.05.020, PMID:", "ArticleIdList": ["10.1016/j.mce.2008.05.020", "18611432"]}, {"Citation": "Biessels GJ, van der Heide LP, Kamal A, Bleys RL, Gispen WH. Ageing and diabetes: implications for brain function. Eur J Pharmacol. (2002) 441:1\u201314. doi: 10.1016/s0014-2999(02)01486-3", "ArticleIdList": ["10.1016/s0014-2999(02)01486-3", "12007915"]}, {"Citation": "Li ZG, Zhang W, Grunberger G, Sima AA. Hippocampal neuronal apoptosis in type 1 diabetes. Brain Res. (2002) 946:221\u201331. doi: 10.1016/s0006-8993(02)02887-1, PMID:", "ArticleIdList": ["10.1016/s0006-8993(02)02887-1", "12137925"]}, {"Citation": "Hu BJ, Hu YN, Lin S, Ma WJ, Li XR. Application of lutein and Zeaxanthin in nonproliferative diabetic retinopathy. Int J Ophthalmol. (2011) 4:303\u20136. doi: 10.3980/j.issn.2222-3959.2011.03.19, PMID:", "ArticleIdList": ["10.3980/j.issn.2222-3959.2011.03.19", "PMC3340817", "22553667"]}, {"Citation": "Moschos MM, Dettoraki M, Tsatsos M, Kitsos G, Kalogeropoulos C. Effect of carotenoids dietary supplementation on macular function in diabetic patients. Eye Vis (Lond). (2017) 4:23\u20134. eCollection 2017. doi: 10.1186/s40662-017-0088-4", "ArticleIdList": ["10.1186/s40662-017-0088-4", "PMC5641400", "29046877"]}, {"Citation": "Chous AP, Richer SP, Gerson JD, Kowluru RA. The diabetes visual function supplement study (DiVFuSS). Br J Ophthalmol. (2016) 100:227\u201334. doi: 10.1136/bjophthalmol-2014-306534, PMID:", "ArticleIdList": ["10.1136/bjophthalmol-2014-306534", "PMC4752618", "26089210"]}, {"Citation": "Zhang PC, Wu CR, Wang ZL, Wang LY, Han Y, Sun SL, et al. . Effect of lutein supplementation on visual function in nonproliferative diabetic retinopathy. Asia Pac J Clin Nutr. (2017) 26:406\u201311. doi: 10.6133/apjcn.032016.13, PMID:", "ArticleIdList": ["10.6133/apjcn.032016.13", "28429904"]}, {"Citation": "Neyestani TR, Shariat-Zadeh N, Gharavi A, Kalayi A, Khalaji N. The opposite associations of lycopene and body fat mass with humoral immunity in type 2 diabetes mellitus: a possible role in atherogenesis. Iran J Allergy Asthma Immunol. (2007) 6:79\u201387. PMID:", "ArticleIdList": ["17563408"]}, {"Citation": "Upritchard JE, Sutherland WH, Mann JI. Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care. (2000) 23:733\u20138. doi: 10.2337/diacare.23.6.733, PMID:", "ArticleIdList": ["10.2337/diacare.23.6.733", "10840987"]}, {"Citation": "Asemi Z, Alizadeh SA, Ahmad K, Goli M, Esmaillzadeh A. Effects of beta-carotene fortified synbiotic food on metabolic control of patients with type 2 diabetes mellitus: a double-blind randomized cross-over controlled clinical trial. Clin Nutr. (2016) 35:819\u201325. doi: 10.1016/j.clnu.2015.07.009, PMID:", "ArticleIdList": ["10.1016/j.clnu.2015.07.009", "26209256"]}, {"Citation": "Coyne T, Ibiebele TI, Baade PD, Dobson A, McClintock C, Dunn S, et al. . Diabetes mellitus and serum carotenoids: findings of a population-based study in Queensland. Australia Am J Clin Nutr. (2005) 82:685\u201393. doi: 10.1093/ajcn.82.3.685, PMID:", "ArticleIdList": ["10.1093/ajcn.82.3.685", "16155284"]}, {"Citation": "Ekesa B, Nabuuma D, Blomme G, Van den Bergh I. Provitamin a carotenoid content of unripe and ripe banana cultivars for potential adoption in eastern Africa. J Food Compos Anal. (2015) 43:1\u20136. doi: 10.1016/j.jfca.2015.04.003", "ArticleIdList": ["10.1016/j.jfca.2015.04.003"]}, {"Citation": "Costa ES, Franca CN, Fonseca FAH, Kato JT, Bianco HT, Freitas TT, et al. . Beneficial effects of green banana biomass consumption in patients with pre-diabetes and type 2 diabetes: a randomised controlled trial. Br J Nutr. (2019) 121:1365\u201375. doi: 10.1017/S0007114519000576, PMID:", "ArticleIdList": ["10.1017/S0007114519000576", "30887937"]}, {"Citation": "Guo XF, Ruan Y, Li ZH, Li D. Flavonoid subclasses and type 2 diabetes mellitus risk: a meta-analysis of prospective cohort studies. Crit Rev Food Sci Nutr. (2019) 59:2850\u201362. doi: 10.1080/10408398.2018.1476964, PMID:", "ArticleIdList": ["10.1080/10408398.2018.1476964", "29768032"]}, {"Citation": "Bondonno NP, Dalgaard F, Murray K, Davey RJ, Bondonno CP, Cassidy A, et al. . Higher habitual flavonoid intakes are associated with a lower incidence of diabetes. J Nutr. (2021) 151:3533\u201342. doi: 10.1093/jn/nxab269, PMID:", "ArticleIdList": ["10.1093/jn/nxab269", "PMC8562076", "34313759"]}, {"Citation": "Adu MD, Bondonno CP, Parmenter BH, Sim M, Davey RJ, Murray K, et al. . Association between non-tea flavonoid intake and risk of type 2 diabetes: the Australian diabetes, obesity and lifestyle study. Food Funct. (2022) 13:4459\u201368. doi: 10.1039/d1fo04209b, PMID:", "ArticleIdList": ["10.1039/d1fo04209b", "35380573"]}, {"Citation": "Chen M, Wang K, Zhang Y, Zhang M, Ma Y, Sun H, et al. . New insights into the biological activities of Chrysanthemum morifolium: natural flavonoids alleviate diabetes by targeting \u03b1-glucosidase and the PTP-1B signaling pathway. Eur J Med Chem. (2019) 178:108\u201315. doi: 10.1016/j.ejmech.2019.05.083, PMID:", "ArticleIdList": ["10.1016/j.ejmech.2019.05.083", "31176093"]}, {"Citation": "Zhang SS, Hou YF, Liu SJ, Guo S, Ho CT, Bai NS. Exploring active ingredients, beneficial effects, and potential mechanism of Allium tenuissimum L. flower for treating T2DM mice based on network pharmacology and gut microbiota. Nutrients. (2022) 14:3980. doi: 10.3390/nu14193980", "ArticleIdList": ["10.3390/nu14193980", "PMC9571170", "36235633"]}, {"Citation": "Beydoun MA, Chen X, Jha K, Beydoun HA, Zonderman AB, Canas JA. Carotenoids, vitamin a, and their association with the metabolic syndrome: a systematic review and meta-analysis. Nutr Rev. (2019) 77:32\u201345. doi: 10.1093/nutrit/nuy044, PMID:", "ArticleIdList": ["10.1093/nutrit/nuy044", "PMC6277204", "30202882"]}, {"Citation": "Sedeek M, Montezano AC, Hebert RL, Gray SP, Marco ED, Jha JC, et al. . Oxidative stress, Nox isoforms and complications of diabetes\u2014potential targets for novel therapies. J Cardiovasc Transl Res. (2012) 5:509\u201318. doi: 10.1007/s12265-012-9387-2, PMID:", "ArticleIdList": ["10.1007/s12265-012-9387-2", "22711281"]}, {"Citation": "Xiao J. Recent advances in dietary flavonoids for management of type 2 diabetes. Curr Opin Food Sci. (2022) 44:100806. doi: 10.1016/j.cofs.2022.01.002", "ArticleIdList": ["10.1016/j.cofs.2022.01.002"]}, {"Citation": "Mihaylova MM, Shaw RJ. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol. (2011) 13:1016\u201323. doi: 10.1038/ncb2329, PMID:", "ArticleIdList": ["10.1038/ncb2329", "PMC3249400", "21892142"]}, {"Citation": "Li Y, Yao J, Han C, Yang J, Chaudhry MT, Wang S, et al. . Quercetin, inflammation and immunity. Nutrients. (2016) 8:167. doi: 10.3390/nu8030167, PMID:", "ArticleIdList": ["10.3390/nu8030167", "PMC4808895", "26999194"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "8", "Day": "16"}, {"Year": "2023", "Month": "2", "Day": "24"}, {"Year": "2023", "Month": "4", "Day": "11", "Hour": "6", "Minute": "1"}, {"Year": "2023", "Month": "4", "Day": "10", "Hour": "3", "Minute": "46"}, {"Year": "2023", "Month": "4", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["37032781", "PMC10080163", "10.3389/fnut.2023.1020950"]}}], "PubmedBookArticle": []}